Menu
Menu
Dr. Vetter is Professor and Chair of the Neurobiology and Anatomy department, and Adjunct Professor in Ophthalmology and Visual Sciences at the University of Utah. After attending McGill University, she attained her PhD from the University of California in San Francisco.
An established neuroscientist, Dr. Vetter has published numerous scientific papers. Her lab focuses on understanding the pathways controlling neural development and degeneration in the retina, as degeneration of retinal neurons can cause progressive blindness in diseases like glaucoma.
Dr. Vetter is a founding member of the first Catalyst for a Cure research consortium and currently serves on the Advisory Board for the Catalyst for a Cure Biomarker Initiative.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2023 all rights reserved.
Print Subscription
We will mail Gleams anywhere in the United States and Canada, but we do not mail internationally. Please sign up for the email edition if you live outside of the US or Canada.
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.